Literature DB >> 15326401

Hepatitis support groups: meeting the information and support needs of hepatitis patients.

Amy B Jessop1, Chari Cohen, Monika M Burke, Molli Conti, Martin Black.   

Abstract

An estimated 5 million Americans are chronically infected with hepatitis B or C. They face socially and clinically significant reductions in mental and physical health. Improved coping and compliance with clinical therapies and harm-reducing behaviors can improve quality of life and, potentially, treatment outcomes. Motivation to join, participation, use, and usefulness of online and in-person hepatitis support groups was examined through observation and survey of group members and group leaders. Members joined primarily to get information particularly about treatments, diet, and treatment side effects. They also joined to get support. All received support that was often hard to get elsewhere. Healthcare providers were generally the most used source of information, yet support groups were the most useful source of information. Members used the information and support obtained to make treatment and lifestyle changes such as initiating or ceasing treatment, eliminating alcohol consumption, increasing openness with family and friends, and discussing side effects with healthcare providers. Providers caring for hepatitis patients should consider recommending support groups to their patients and also participate in the groups to ensure that valid and reliable information is provided.

Entities:  

Mesh:

Year:  2004        PMID: 15326401     DOI: 10.1097/00001610-200407000-00004

Source DB:  PubMed          Journal:  Gastroenterol Nurs        ISSN: 1042-895X            Impact factor:   0.978


  4 in total

1.  Physical, social, and psychological consequences of treatment for hepatitis C : a community-based evaluation of patient-reported outcomes.

Authors:  M Michele Manos; Chanda K Ho; Rosemary C Murphy; Valentina A Shvachko
Journal:  Patient       Date:  2013       Impact factor: 3.883

Review 2.  Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease.

Authors:  Patricia C Valery; Elizabeth Powell; Neta Moses; Michael L Volk; Steven M McPhail; Paul J Clark; Jennifer Martin
Journal:  BMJ Open       Date:  2015-04-08       Impact factor: 2.692

3.  Patients with rare diseases using pharmacists for medication information.

Authors:  Delesha M Carpenter; Susan J Blalock; Robert F DeVellis
Journal:  J Am Pharm Assoc (2003)       Date:  2012

4.  Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection.

Authors:  Lauren Fusfeld; Jyoti Aggarwal; Carly Dougher; Montserrat Vera-Llonch; Stephen Bubb; Mrudula Donepudi; Thomas F Goss
Journal:  BMC Infect Dis       Date:  2013-05-23       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.